These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 23857813)

  • 21. Plasma soluble L-selectin in medicated patients with schizophrenia and healthy controls.
    Mohite S; Yang F; Amin PA; Zunta-Soares G; Colpo GD; Stertz L; Sharma AN; Fries GR; Walss-Bass C; Soares JC; Okusaga OO
    PLoS One; 2017; 12(3):e0174073. PubMed ID: 28334045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased ratio of high sensitivity C-reactive protein to interleukin-10 as a potential peripheral biomarker of schizophrenia and aggression.
    Zhang Q; Hong W; Li H; Peng F; Wang F; Li N; Xiang H; Zhang Z; Su Y; Huang Y; Zhang S; Zhao G; Zhou R; Mao L; Lin Z; Cai W; Fang Y; Xie B; Zhao M
    Int J Psychophysiol; 2017 Apr; 114():9-15. PubMed ID: 28174109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein levels and treatment resistance in schizophrenia-A Danish population-based cohort study.
    Horsdal HT; Wimberley T; Benros ME; Gasse C
    Hum Psychopharmacol; 2017 Nov; 32(6):. PubMed ID: 28952165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of serum steroid hormones in schizophrenic patients.
    Taherianfard M; Shariaty M
    Indian J Med Sci; 2004 Jan; 58(1):3-9. PubMed ID: 14960795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [C-reactive protein and agitation in patients with schizophrenia: A cohort study with a control group].
    Kachouchi A; Sebbani M; Akammar S; Berghalout M; Adali I; Manoudi F; Amine M; Asri F
    Encephale; 2020 Aug; 46(4):264-268. PubMed ID: 32057410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Serum immunological markers as predictors of effectiveness of antipsychotic therapy in patients with schizophrenia].
    Klushnik TP; Syriachenko TM; Brusov OS; Sarmanova ZV; Otman IN; Dupin AM; Sokolov RE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(1):31-5. PubMed ID: 18427517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-reactive protein levels in schizophrenia: a review and meta-analysis.
    Miller BJ; Culpepper N; Rapaport MH
    Clin Schizophr Relat Psychoses; 2014 Jan; 7(4):223-30. PubMed ID: 23428789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma complement component 4 alterations in patients with schizophrenia before and after antipsychotic treatment.
    Su J; Feng X; Chen K; Fang Z; Zhang H
    Asian J Psychiatr; 2022 Jul; 73():103110. PubMed ID: 35430500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Could CRP be a differential biomarker of illness stages in schizophrenia? A systematic review and meta-analysis.
    Lestra V; Romeo B; Martelli C; Benyamina A; Hamdani N
    Schizophr Res; 2022 Aug; 246():175-186. PubMed ID: 35785580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anemia among schizophrenic patients: influence of clozapine and C-reactive protein.
    Lozano R; Franco ME; Marin R; Santacruz MJ
    J Clin Psychiatry; 2016 Apr; 77(4):e467. PubMed ID: 27137431
    [No Abstract]   [Full Text] [Related]  

  • 31. Serum level of high sensitive C-reactive protein and IL - 6 markers in patients with treatment-resistant schizophrenia in Ethiopia: a comparative study.
    Challa F; Seifu D; Sileshi M; Getahun T; Geto Z; Kassa D; Alemayehu M; Mesfin M; Fekadu A; Woldeamanuel Y
    BMC Psychiatry; 2021 Aug; 21(1):428. PubMed ID: 34465310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Both physical activity and food intake are associated with metabolic risks in patients with schizophrenia.
    Wang J; Fan X; Liu D; Yi Z; Freudenreich O; Goff D; Henderson DC
    Schizophr Res; 2012 Sep; 140(1-3):260-1. PubMed ID: 22682987
    [No Abstract]   [Full Text] [Related]  

  • 33. Cannabis Cessation, Inflammatory Markers and Schizophrenia.
    Romeo B; Lestra V; Martelli C; Benyamina A; Hamdani N
    J Dual Diagn; 2022; 18(1):33-41. PubMed ID: 34985404
    [No Abstract]   [Full Text] [Related]  

  • 34. Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review.
    Orsolini L; Sarchione F; Vellante F; Fornaro M; Matarazzo I; Martinotti G; Valchera A; Di Nicola M; Carano A; Di Giannantonio M; Perna G; Olivieri L; De Berardis D
    Curr Neuropharmacol; 2018; 16(5):583-606. PubMed ID: 29357805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated serum levels of high-sensitivity C-reactive proteins are associated with severe delusional symptoms in a subgroup of patients with schizophrenia.
    Dimitrov DH; Lee S; Yantis J; Honaker C; Braida N; Walss-Bass C
    J Clin Psychiatry; 2016 Jan; 77(1):131-2. PubMed ID: 26845270
    [No Abstract]   [Full Text] [Related]  

  • 36. Plasma phenylethylamine levels of schizophrenic patients.
    Shirkande S; O'Reilly R; Davis B; Durden D; Malcom D
    Can J Psychiatry; 1995 May; 40(4):221. PubMed ID: 7621397
    [No Abstract]   [Full Text] [Related]  

  • 37. High-sensitivity C-reactive protein is related to age and gender in an acute psychiatric inpatient population.
    Sakai Y; Larsen JB; Reitan SK
    Heliyon; 2022 Feb; 8(2):e08992. PubMed ID: 35243104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Commentary: Physical Functional Capacity and C-Reactive Protein in Schizophrenia.
    Elliesen R; Walther A
    Front Psychiatry; 2018; 9():7. PubMed ID: 29434554
    [No Abstract]   [Full Text] [Related]  

  • 39. C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications.
    Fernandes BS; Steiner J; Bernstein HG; Dodd S; Pasco JA; Dean OM; Nardin P; Gonçalves CA; Berk M
    Mol Psychiatry; 2016 Apr; 21(4):554-64. PubMed ID: 26169974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Comparison of the Relationship Between C-Reactive Protein Levels and Cognitive Functions in Patients with Schizophrenia, First-Episode Psychosis, and Healthy Controls.
    Demir N; Yıldırım O
    Psychiatry Clin Psychopharmacol; 2022 Dec; 32(4):274-284. PubMed ID: 38764885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.